PROM / USDT

SOMI / FDUSD

SOMI / USDT

MUBARAK / USDT

SOMI / TRY

SOMI / USDC

MUBARAK / TRY

MUBARAK / USDC

SOMI / BNB

TST / USDC

BAKE / BTC

BAKE / TRY

BAKE / USDT

HIFI / USDT

SLF / BTC

SLF / TRY

SLF / USDT

LA / FDUSD

C / BNB

LINEA / BNB

QMS MEDI LTD

TAURIAN MPS LIMITED

KOTHARI PRODUCTS LTD

REDINGTON LIMITED

LAXMI DENTAL LIMITED

PAVNA INDUSTRIES LIMITED

SINDHU TRADE LINKS LTD

MIRZA INTERNATIONAL LIMIT

DUCON INFRATECHNOLOGIES L

ALLIED DIGITAL SERV. LTD

GODFREY PHILLIPS INDIA LT

SHRADHA INFRAPROJECTS LTD

JITF INFRALOGISTICS LTD

APRAMEYA ENGINEERING LTD

RITE ZONE CHEMCON IND LTD

MY MUDRA FINCORP LIMITED

LE TRAVENUES TECHNOLOGY L

P. E. ANALYTICS LIMITED

MAGNUM VENTURES LTD.

ANIK INDUSTRIES LTD

Click here to get full coverage on Morning Download: Nevada alum Austin Corbett suffers another major knee injury, goes on IR - Nevada Sports Net

Morning Download: Nevada alum Austin Corbett suffers another major knee injury, goes on IR  Nevada Sports Net

Morning Download: Nevada alum Austin Corbett suffers another major knee injury, goes on IR - Nevada Sports Net

Click here to get full coverage on Dr Arora on the Associations Between Income and Race and MCL Survival Outcomes - OncLive

Dr Arora on the Associations Between Income and Race and MCL Survival Outcomes  OncLive

Dr Arora on the Associations Between Income and Race and MCL Survival Outcomes - OncLive

Click here to get full coverage on Indiana Fever Confirms Season-Ending MCL Injury to Sophie Cunningham - Just Women's Sports

Indiana Fever Confirms Season-Ending MCL Injury to Sophie Cunningham  Just Women's Sports

Indiana Fever Confirms Season-Ending MCL Injury to Sophie Cunningham - Just Women's Sports

Click here to get full coverage on Jared Gordon was hit by a car, suffered MCL injury just hours before Noche UFC defeat - BJPenn.com

Jared Gordon was hit by a car, suffered MCL injury just hours before Noche UFC defeat  BJPenn.com

Jared Gordon was hit by a car, suffered MCL injury just hours before Noche UFC defeat - BJPenn.com

Click here to get full coverage on 🏈 Smith Center edges Phillipsburg in MCL rivalry showdown - Hays Post

🏈 Smith Center edges Phillipsburg in MCL rivalry showdown  Hays Post

🏈 Smith Center edges Phillipsburg in MCL rivalry showdown - Hays Post

Click here to get full coverage on Panthers Placing G Robert Hunt (Biceps) & C Austin Corbett (MCL) On IR - NFLTradeRumors.co

Panthers Placing G Robert Hunt (Biceps) & C Austin Corbett (MCL) On IR  NFLTradeRumors.co

Panthers Placing G Robert Hunt (Biceps) & C Austin Corbett (MCL) On IR - NFLTradeRumors.co

Click here to get full coverage on BTK Inhibitors Lead to Decreased Health Care Resource Utilization in MCL - OncLive

BTK Inhibitors Lead to Decreased Health Care Resource Utilization in MCL  OncLive

BTK Inhibitors Lead to Decreased Health Care Resource Utilization in MCL - OncLive

Click here to get full coverage on Sources: Steelers DT Harmon out with MCL sprain - ESPN

Sources: Steelers DT Harmon out with MCL sprain  ESPN

Sources: Steelers DT Harmon out with MCL sprain - ESPN

Click here to get full coverage on BeOne Medicines (ONC) Reports Positive Phase 1/2 Results for Sonrotoclax in MCL - Yahoo Finance

BeOne Medicines (ONC) Reports Positive Phase 1/2 Results for Sonrotoclax in MCL  Yahoo Finance

BeOne Medicines (ONC) Reports Positive Phase 1/2 Results for Sonrotoclax in MCL - Yahoo Finance

Click here to get full coverage on High-risk MCL: recognition and treatment - ScienceDirect.com

High-risk MCL: recognition and treatment  ScienceDirect.com

High-risk MCL: recognition and treatment - ScienceDirect.com

Click here to get full coverage on Refractory MCL: Mosunetuzumab-Polatuzumab Combo Effective - Medscape

Refractory MCL: Mosunetuzumab-Polatuzumab Combo Effective  Medscape

Refractory MCL: Mosunetuzumab-Polatuzumab Combo Effective - Medscape

Click here to get full coverage on Skiff, Sandoval to Represent Purdue Calumet in MCL All-Star Game - GreatNews.Life

Skiff, Sandoval to Represent Purdue Calumet in MCL All-Star Game  GreatNews.Life

Skiff, Sandoval to Represent Purdue Calumet in MCL All-Star Game - GreatNews.Life

Click here to get full coverage on Legal challenges cloud future of PFAS regulation as EPA moves to vacate PFAS MCL - waterworld.com

Legal challenges cloud future of PFAS regulation as EPA moves to vacate PFAS MCL  waterworld.com

Legal challenges cloud future of PFAS regulation as EPA moves to vacate PFAS MCL - waterworld.com

Click here to get full coverage on Symposium | Current therapies for MCL and their combinations - Lymphoma Hub

Symposium | Current therapies for MCL and their combinations  Lymphoma Hub

Symposium | Current therapies for MCL and their combinations - Lymphoma Hub

Click here to get full coverage on MCL‑1 safeguards activated hair follicle stem cells to enable adult hair regeneration - Nature

MCL‑1 safeguards activated hair follicle stem cells to enable adult hair regeneration  Nature

MCL‑1 safeguards activated hair follicle stem cells to enable adult hair regeneration - Nature

Click here to get full coverage on 🏈🎥 TMP travels to Norton for MCL showdown - Hays Post

🏈🎥 TMP travels to Norton for MCL showdown  Hays Post

🏈🎥 TMP travels to Norton for MCL showdown - Hays Post

Click here to get full coverage on Structural basis of BAK sequestration by MCL-1 in apoptosis - ScienceDirect.com

Structural basis of BAK sequestration by MCL-1 in apoptosis  ScienceDirect.com

Structural basis of BAK sequestration by MCL-1 in apoptosis - ScienceDirect.com

Click here to get full coverage on Source: LeBron suffered MCL sprain in G5 loss - ESPN

Source: LeBron suffered MCL sprain in G5 loss  ESPN

Source: LeBron suffered MCL sprain in G5 loss - ESPN

Click here to get full coverage on Treatment of relapsed/refractory MCL - ScienceDirect.com

Treatment of relapsed/refractory MCL  ScienceDirect.com

Treatment of relapsed/refractory MCL - ScienceDirect.com

Click here to get full coverage on European Commission Approves Ibrutinib in Treatment-Naive, Transplant-Eligible MCL - OncLive

European Commission Approves Ibrutinib in Treatment-Naive, Transplant-Eligible MCL  OncLive

European Commission Approves Ibrutinib in Treatment-Naive, Transplant-Eligible MCL - OncLive

Click here to get full coverage on Symposium | Unmet needs in the treatment of MCL - Lymphoma Hub

Symposium | Unmet needs in the treatment of MCL  Lymphoma Hub

Symposium | Unmet needs in the treatment of MCL - Lymphoma Hub

Click here to get full coverage on Dr Danilov on the Evolution of Chemotherapy-Free Treatment Options in MCL - OncLive

Dr Danilov on the Evolution of Chemotherapy-Free Treatment Options in MCL  OncLive

Dr Danilov on the Evolution of Chemotherapy-Free Treatment Options in MCL - OncLive

Click here to get full coverage on EC Approves Ibrutinib Plus Chemoimmunotherapy +/- ASCT in Untreated MCL - CancerNetwork

EC Approves Ibrutinib Plus Chemoimmunotherapy +/- ASCT in Untreated MCL  CancerNetwork

EC Approves Ibrutinib Plus Chemoimmunotherapy +/- ASCT in Untreated MCL - CancerNetwork

Click here to get full coverage on Sophie Cunningham confirms MCL tear, says she has 'nothing but love' for Sun's Bria Hartley after collision - Yahoo Sports

Sophie Cunningham confirms MCL tear, says she has 'nothing but love' for Sun's Bria Hartley after collision  Yahoo Sports

Sophie Cunningham confirms MCL tear, says she has 'nothing but love' for Sun's Bria Hartley after collision - Yahoo Sports

Click here to get full coverage on Combining MCL-1 inhibition and CD37-directed chimeric antigen receptor T cells as an effective strategy to target T-cell lymphoma | Leukemia - Nature

Combining MCL-1 inhibition and CD37-directed chimeric antigen receptor T cells as an effective strategy to target T-cell lymphoma | Leukemia  Nature

Combining MCL-1 inhibition and CD37-directed chimeric antigen receptor T cells as an effective strategy to target T-cell lymphoma | Leukemia - Nature

Click here to get full coverage on BOVen Regimen Is Safe and Effective in First-Line TP53-Mutated MCL - OncLive

BOVen Regimen Is Safe and Effective in First-Line TP53-Mutated MCL  OncLive

BOVen Regimen Is Safe and Effective in First-Line TP53-Mutated MCL - OncLive

Click here to get full coverage on MCL 3-0 MUN Highlights, Premier League 2025-26: Haaland, Foden guide Manchester City past Manchester United - Sportstar

MCL 3-0 MUN Highlights, Premier League 2025-26: Haaland, Foden guide Manchester City past Manchester United  Sportstar

MCL 3-0 MUN Highlights, Premier League 2025-26: Haaland, Foden guide Manchester City past Manchester United - Sportstar

Click here to get full coverage on MCL using raffles to celebrate Library Card Sign-Up Month - Daily Chief-Union

MCL using raffles to celebrate Library Card Sign-Up Month  Daily Chief-Union

MCL using raffles to celebrate Library Card Sign-Up Month - Daily Chief-Union

Click here to get full coverage on End of racing era as Speedway MCL closes: 'Indy 500 drivers, teams basically lived there' - IndyStar

End of racing era as Speedway MCL closes: 'Indy 500 drivers, teams basically lived there'  IndyStar

End of racing era as Speedway MCL closes: 'Indy 500 drivers, teams basically lived there' - IndyStar

Click here to get full coverage on Arthroscopic treatment of medial collateral ligament femoral insertion tears with concomitant cruciate ligament injuries: A novel technical report - ScienceDirect.com

Arthroscopic treatment of medial collateral ligament femoral insertion tears with concomitant cruciate ligament injuries: A novel technical report  ScienceDirect.com

Arthroscopic treatment of medial collateral ligament femoral insertion tears with concomitant cruciate ligament injuries: A novel technical report - ScienceDirect.com

Click here to get full coverage on Dr Kahl on the Evolving Role of BTK Inhibitors in MCL - OncLive

Dr Kahl on the Evolving Role of BTK Inhibitors in MCL  OncLive

Dr Kahl on the Evolving Role of BTK Inhibitors in MCL - OncLive

Click here to get full coverage on Src inhibition potentiates MCL-1 antagonist activity in acute myeloid leukemia - Nature

Src inhibition potentiates MCL-1 antagonist activity in acute myeloid leukemia  Nature

Src inhibition potentiates MCL-1 antagonist activity in acute myeloid leukemia - Nature

Click here to get full coverage on Symposium | Customizing therapy for MCL: Q&A - Lymphoma Hub

Symposium | Customizing therapy for MCL: Q&A  Lymphoma Hub

Symposium | Customizing therapy for MCL: Q&A - Lymphoma Hub

Click here to get full coverage on Overexpression of MCL-1 in canine hepatocellular carcinoma and its efficacy as a prognostic marker - BMC Veterinary Research

Overexpression of MCL-1 in canine hepatocellular carcinoma and its efficacy as a prognostic marker  BMC Veterinary Research

Overexpression of MCL-1 in canine hepatocellular carcinoma and its efficacy as a prognostic marker - BMC Veterinary Research

Click here to get full coverage on Steelers S DeShon Elliott to miss several weeks with MCL sprain - Steelers Wire

Steelers S DeShon Elliott to miss several weeks with MCL sprain  Steelers Wire

Steelers S DeShon Elliott to miss several weeks with MCL sprain - Steelers Wire

Click here to get full coverage on Superoxide-mediated phosphorylation and stabilization of Mcl-1 by AKT underlie venetoclax resistance in hematologic malignancies | Leukemia - Nature

Superoxide-mediated phosphorylation and stabilization of Mcl-1 by AKT underlie venetoclax resistance in hematologic malignancies | Leukemia  Nature

Superoxide-mediated phosphorylation and stabilization of Mcl-1 by AKT underlie venetoclax resistance in hematologic malignancies | Leukemia - Nature

Click here to get full coverage on Steelers' Derrick Harmon expected to miss month with MCL sprain, report says - CBS News

Steelers' Derrick Harmon expected to miss month with MCL sprain, report says  CBS News

Steelers' Derrick Harmon expected to miss month with MCL sprain, report says - CBS News

Click here to get full coverage on LeBron James won't be attending the Met Gala because of MCL sprain - FOX Sports

LeBron James won't be attending the Met Gala because of MCL sprain  FOX Sports

LeBron James won't be attending the Met Gala because of MCL sprain - FOX Sports

Click here to get full coverage on Leeds midfielder Ao Tanaka to miss several weeks with MCL injury - The Athletic - The New York Times

Leeds midfielder Ao Tanaka to miss several weeks with MCL injury - The Athletic  The New York Times

Leeds midfielder Ao Tanaka to miss several weeks with MCL injury - The Athletic - The New York Times

Click here to get full coverage on Recent advances of small-molecule Mcl-1 inhibitors or degraders as promising anti-cancer agents (2018-present) - ScienceDirect.com

Recent advances of small-molecule Mcl-1 inhibitors or degraders as promising anti-cancer agents (2018-present)  ScienceDirect.com

Recent advances of small-molecule Mcl-1 inhibitors or degraders as promising anti-cancer agents (2018-present) - ScienceDirect.com

Click here to get full coverage on FDA Approves Acalabrutinib Combo in Previously Untreated MCL - CancerNetwork

FDA Approves Acalabrutinib Combo in Previously Untreated MCL  CancerNetwork

FDA Approves Acalabrutinib Combo in Previously Untreated MCL - CancerNetwork

Click here to get full coverage on Symposium | Sequencing therapies and practical management of adverse events in MCL - Lymphoma Hub

Symposium | Sequencing therapies and practical management of adverse events in MCL  Lymphoma Hub

Symposium | Sequencing therapies and practical management of adverse events in MCL - Lymphoma Hub

Click here to get full coverage on Oleuropein regulates ubiquitination-mediated Mcl-1 turnover and exhibits antitumor activity - Nature

Oleuropein regulates ubiquitination-mediated Mcl-1 turnover and exhibits antitumor activity  Nature

Oleuropein regulates ubiquitination-mediated Mcl-1 turnover and exhibits antitumor activity - Nature

Click here to get full coverage on Markstrom out 4-6 weeks for Devils with sprained MCL - NHL.com

Markstrom out 4-6 weeks for Devils with sprained MCL  NHL.com

Markstrom out 4-6 weeks for Devils with sprained MCL - NHL.com

Click here to get full coverage on Landmark discovery reshapes understanding of key cancer protein MCL-1 - News-Medical

Landmark discovery reshapes understanding of key cancer protein MCL-1  News-Medical

Landmark discovery reshapes understanding of key cancer protein MCL-1 - News-Medical

Click here to get full coverage on Declining MCL Incidence Aligns With Broader Lymphoma Trends, But Survival Disparities Persist - OncLive

Declining MCL Incidence Aligns With Broader Lymphoma Trends, But Survival Disparities Persist  OncLive

Declining MCL Incidence Aligns With Broader Lymphoma Trends, But Survival Disparities Persist - OncLive

Click here to get full coverage on Deciphering molecular specificity in MCL-1/BAK interaction and its implications for designing potent MCL-1 inhibitors - Nature

Deciphering molecular specificity in MCL-1/BAK interaction and its implications for designing potent MCL-1 inhibitors  Nature

Deciphering molecular specificity in MCL-1/BAK interaction and its implications for designing potent MCL-1 inhibitors - Nature

Click here to get full coverage on Tipping the balance of cell death: alternative splicing as a source of MCL-1S in cancer - Nature

Tipping the balance of cell death: alternative splicing as a source of MCL-1S in cancer  Nature

Tipping the balance of cell death: alternative splicing as a source of MCL-1S in cancer - Nature

Click here to get full coverage on Unraveling MCL biology to understand resistance and identify vulnerabilities - ScienceDirect.com

Unraveling MCL biology to understand resistance and identify vulnerabilities  ScienceDirect.com

Unraveling MCL biology to understand resistance and identify vulnerabilities - ScienceDirect.com

Click here to get full coverage on Mcl-1 downregulation enhances BCG treatment efficacy in bladder cancer by promoting macrophage polarization - Cancer Cell International

Mcl-1 downregulation enhances BCG treatment efficacy in bladder cancer by promoting macrophage polarization  Cancer Cell International

Mcl-1 downregulation enhances BCG treatment efficacy in bladder cancer by promoting macrophage polarization - Cancer Cell International

Click here to get full coverage on R )-WAC-224, a new anticancer quinolone, combined with venetoclax and azacitidine overcomes venetoclax-resistant AML through MCL-1 downregulation - Nature

R )-WAC-224, a new anticancer quinolone, combined with venetoclax and azacitidine overcomes venetoclax-resistant AML through MCL-1 downregulation  Nature

R )-WAC-224, a new anticancer quinolone, combined with venetoclax and azacitidine overcomes venetoclax-resistant AML through MCL-1 downregulation - Nature

Click here to get full coverage on MCL-1 as a potent target for cancer: Recent advancements, structural insights and SAR studies - ScienceDirect.com

MCL-1 as a potent target for cancer: Recent advancements, structural insights and SAR studies  ScienceDirect.com

MCL-1 as a potent target for cancer: Recent advancements, structural insights and SAR studies - ScienceDirect.com

Click here to get full coverage on Germany captain Gwinn out of Euro 2025 with MCL - ESPN

Germany captain Gwinn out of Euro 2025 with MCL  ESPN

Germany captain Gwinn out of Euro 2025 with MCL - ESPN

Click here to get full coverage on Yan Leyfman: Dual-Targeted CAR-T Therapy Shows 100% Response in MCL - Oncodaily

Yan Leyfman: Dual-Targeted CAR-T Therapy Shows 100% Response in MCL  Oncodaily

Madhav Copper Limited (MCL)

Price Chart

Key Statistics

Technicals

About MCL

Latest News

Morning Download: Nevada alum Austin Corbett suffers another major knee injury, goes on IR - Nevada Sports Net

Dr Arora on the Associations Between Income and Race and MCL Survival Outcomes - OncLive

Indiana Fever Confirms Season-Ending MCL Injury to Sophie Cunningham - Just Women's Sports

Advanced Charts

Top Gainers

Top Losers